Sophia CDMO

Overview

Sophia CDMO is a European contract development and manufacturing organization built around integrated process development, analytical development, GMP manufacturing, and quality systems for biologics and fermentation-enabled products. The company operates as a single platform across two headquarters:

• Pamplona, Spain: Microbial and precision fermentation scale-up to 20,000 L
• Basel, Switzerland: Large-scale biomanufacturing capacity up to 40,000 L

Core Capabilities

Fermentation & Upstream Processing

• Microbial upstream optimization and scale-up planning
• E. coli recombinant protein expression
• Fungal protein expression (Pichia)
• Strict anaerobe fermentation
• Yeast strain engineering and cell banking

Downstream Processing & Manufacturing

• Downstream development with impurity and endotoxin-aware strategies
• Hold-time, robustness, and process consistency planning
• Sterile fill-finish services
• Blow-fill-seal manufacturing
• Lyophilized injectable manufacturing

Analytical & Development Services

• Analytical method development
• Characterization and stability strategies
• Extractables and leachables testing
• Biosimilar analytics
• Process development aligned to CMC decision-making

Specialized Modalities & Markets

• Animal health biologics
• Probiotics and postbiotics
• Live biotherapeutic products
• mRNA LNP formulation
• Exosomes (microbial and plant-derived)
• Circular RNA
• siRNA
• Cosmetic bioactives and skincare formulations
• Drug-device combinations

Operating Model

Sophia's differentiation centers on integrated execution: process development, analytics, manufacturing, and quality systems operate as one program rather than fragmented vendor handoffs. The company emphasizes early control strategy definition, analytics-driven process decisions, right-first-time documentation, governance discipline, and continuous improvement embedded in manufacturing operations.